The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,936
Sort by:
U.S. Urinary Incontinence Therapeutics Market Size, Share & Trends Analysis Report By Type (Stress Incontinence, Urge Incontinence), By Drug Class, By Gender, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
The U.S. urinary incontinence therapeutics market size was estimated at USD 1.55 billion in 2024 and is projected to reach USD 2.41 billion by 2033, growing at a CAGR of 5.06% from 2025 to 2033. The U...
November 2025
150 pages
Asia Pacific Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Asia Pacific bacterial vaginosis (BV) drug market is projected to experience significant growth, with an expected market size of approximately US$ 691.1 million by 2031, up from US$ 380.6 million...
November 2025
167 pages
Asia Pacific Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Asia Pacific Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 508.7 billion by 2031, up from US$ 304.0 billion in 2024. This growth represents a compound ann...
November 2025
230 pages
Europe Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Europe Bacterial Vaginosis (BV) Drug Market is projected to grow significantly, reaching an estimated US$ 1,060.6 million by 2031, up from US$ 607.2 million in 2024. This growth represents a compo...
November 2025
165 pages
Europe Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Europe Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 537.6 billion by 2031, up from US$ 335.0 billion in 2024, reflecting a compound annual growth rate (C...
November 2025
225 pages
Middle East & Africa Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Middle East and Africa Bacterial Vaginosis (BV) Drug Market is projected to grow significantly, reaching an estimated US$ 150.5 million by 2031, up from US$ 89.7 million in 2024. This growth repre...
November 2025
156 pages
Middle East & Africa Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Middle East & Africa (MEA) Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 64.4 billion by 2031, up from US$ 41.7 billion in 2024. This growth represents a...
November 2025
218 pages
North America Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The North America Bacterial Vaginosis Drug Market is projected to grow significantly, reaching an estimated US$ 1,688.3 million by 2031, up from US$ 942.6 million in 2024. This growth represents a com...
November 2025
143 pages
North America Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The North America Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 1,157.0 billion by 2031, up from US$ 707.7 billion in 2024, reflecting a compound annual growt...
November 2025
210 pages
South & Central America Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The South and Central America Bacterial Vaginosis (BV) Drug Market is projected to grow significantly, reaching an estimated US$ 236.6 million by 2031, up from US$ 139.1 million in 2024. This growth r...
November 2025
149 pages
South & Central America Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The South & Central America Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 82.5 billion by 2031, up from US$ 52.5 billion in 2024. This growth represents a com...
November 2025
212 pages
Global Testosterone Replacement Therapy Market - 2025-2033
US$ 3,400.00
Global Testosterone Replacement Therapy Market reached US$1.98Billion in 2024 and is expected to reach US$2.74Billion by 2033, growing with a CAGR of 7.70% during the forecast period 2026-2033. The Gl...
November 2025
65 pages
Global Thrombocytopenia Management Market - 2025-2033
US$ 3,400.00
Global Thrombocytopenia Management Marketis is growing with a CAGR of 7.70% during the forecast period 2026-2035. The Global Thrombocytopenia Management Market emerges as a key focus in DataM Intellig...
November 2025
60 pages
Nucleoside Analogues Market - 2024-2031
US$ 3,400.00
The Nucleoside Analogues Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
November 2025
46 pages
Immunotherapy Drugs: Global Markets
US$ 4,650.00
The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% duri...
November 2025
231 pages
Global Bexarotene Market Growth 2025-2031
US$ 3,660.00
The global Bexarotene market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Bexarotene is e...
November 2025
80 pages
Global Colesevelam Hydrochloride Market Growth 2025-2031
US$ 3,660.00
The global Colesevelam Hydrochloride market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for...
November 2025
84 pages
Global Dolasetron Mesylate Market Growth 2025-2031
US$ 3,660.00
The global Dolasetron Mesylate market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Dolase...
November 2025
103 pages
Global Fomepizole API Market Growth 2025-2031
US$ 3,660.00
The global Fomepizole API market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceutical market is...
November 2025
75 pages
Global Salcaprozate Sodium (SNAC) Market Growth 2025-2031
US$ 3,660.00
The global Salcaprozate Sodium (SNAC) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for...
November 2025
83 pages
Global Bimatoprost Market Growth 2025-2031
US$ 3,660.00
The global Bimatoprost market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Bimatoprost is...
November 2025
76 pages
Global Ion Antibacterial Agent Market Growth 2025-2031
US$ 3,660.00
The global Ion Antibacterial Agent market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. An ion antibacterial agent...
November 2025
155 pages
Global Pharma Grade Calcium Sulphate Market Growth 2025-2031
US$ 3,660.00
The global Pharma Grade Calcium Sulphate market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceut...
November 2025
79 pages
Global Acetaminophen API Market Growth 2025-2031
US$ 3,660.00
The global Acetaminophen API market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceutical market...
November 2025
123 pages
Global Amphetamine Aspartate Market Growth 2025-2031
US$ 3,660.00
The global Amphetamine Aspartate market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Amph...
November 2025
78 pages
Global Beta Cyclodextrin Excipients Market Growth 2025-2031
US$ 3,660.00
The global Beta Cyclodextrin Excipients market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market f...
November 2025
88 pages
Global Hidrosmin Market Growth 2025-2031
US$ 3,660.00
The global Hidrosmin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Hidrosmin is est...
November 2025
79 pages
